Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.
Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, Mego M, Handy BC, Ueno NT, Alvarez RH, De Laurentiis M, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Giuliano M, et al. Among authors: giordano a. Breast Cancer Res. 2011 Jun 15;13(3):R67. doi: 10.1186/bcr2907. Breast Cancer Res. 2011. PMID: 21699723 Free PMC article.
CTCs in metastatic breast cancer.
Giordano A, Cristofanilli M. Giordano A, et al. Recent Results Cancer Res. 2012;195:193-201. doi: 10.1007/978-3-642-28160-0_18. Recent Results Cancer Res. 2012. PMID: 22527507 Review.
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A, Gao H, Anfossi S, Cohen E, Mego M, Lee BN, Tin S, De Laurentiis M, Parker CA, Alvarez RH, Valero V, Ueno NT, De Placido S, Mani SA, Esteva FJ, Cristofanilli M, Reuben JM. Giordano A, et al. Mol Cancer Ther. 2012 Nov;11(11):2526-34. doi: 10.1158/1535-7163.MCT-12-0460. Epub 2012 Sep 12. Mol Cancer Ther. 2012. PMID: 22973057 Free PMC article.
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.
Mego M, Gao H, Lee BN, Cohen EN, Tin S, Giordano A, Wu Q, Liu P, Nieto Y, Champlin RE, Hortobagyi GN, Cristofanilli M, Ueno NT, Reuben JM. Mego M, et al. Among authors: giordano a. J Cancer. 2012;3:369-80. doi: 10.7150/jca.5111. Epub 2012 Sep 8. J Cancer. 2012. PMID: 23074378 Free PMC article.
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. Anfossi S, et al. Among authors: giordano a. PLoS One. 2014 Jan 8;9(1):e83113. doi: 10.1371/journal.pone.0083113. eCollection 2014. PLoS One. 2014. PMID: 24416156 Free PMC article.
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT, Alvarez RH, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Giuliano M, et al. Among authors: giordano a. Breast Cancer Res. 2014 Sep 16;16(5):440. doi: 10.1186/s13058-014-0440-8. Breast Cancer Res. 2014. PMID: 25223629 Free PMC article.
Circulating tumor cells in newly diagnosed inflammatory breast cancer.
Mego M, Giordano A, De Giorgi U, Masuda H, Hsu L, Giuliano M, Fouad TM, Dawood S, Ueno NT, Valero V, Andreopoulou E, Alvarez RH, Woodward WA, Hortobagyi GN, Cristofanilli M, Reuben JM. Mego M, et al. Among authors: giordano a. Breast Cancer Res. 2015 Jan 9;17(1):2. doi: 10.1186/s13058-014-0507-6. Breast Cancer Res. 2015. PMID: 25572591 Free PMC article.
2,823 results